Abstract
To the Editor.— In a letter toThe Journal(241:1686, 1979), Blume and Beutler reported impressive survival data following bone marrow transplants performed between 1976 and 1978 in 11 patients with acute leukemia in remission. They expressed concern that an article from the International Bone Marrow Transplant Registry 1 may create an unjustified negative attitude toward bone marrow transplantation in the treatment of acute leukemia. It is apparent that Blume and Beutler missed the point of the Registry article. The report from the Registry comprised 57 patients who were treated with bone marrow transplantation for end-stage acute myeloblastic leukemia (AML). The patients were treated between 1968 and 1976, when marrow transplantation was considered to be highly experimental and was attempted only after repeated failures with more conventional forms of therapy. Despite the fact that all of the patients in the Registry report were in relapse at the time of transplantation, analysis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
